18 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33668794 | The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib. | 2021 Feb 25 | 1 |
2 | 34768548 | Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. | 2021 Oct 28 | 1 |
3 | 34831075 | High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors. | 2021 Oct 22 | 2 |
4 | 32139666 | Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. | 2020 Mar 5 | 1 |
5 | 31213829 | Progress in the identification of gene mutations involved in multiple myeloma. | 2019 | 1 |
6 | 27647225 | Reduced response of IRE1α/Xbp-1 signaling pathway to bortezomib contributes to drug resistance in multiple myeloma cells. | 2017 May 12 | 7 |
7 | 27169614 | Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma. | 2016 Sep | 2 |
8 | 27631436 | Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells. | 2016 Dec | 1 |
9 | 24497562 | High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. | 2014 Feb | 1 |
10 | 24029222 | Why proteasome inhibitors cannot ERADicate multiple myeloma. | 2013 Sep 9 | 1 |
11 | 24029229 | Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma. | 2013 Sep 9 | 1 |
12 | 21993678 | Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1. | 2012 Jan | 7 |
13 | 22266985 | Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. | 2012 May | 1 |
14 | 21447826 | Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. | 2011 Jun 9 | 1 |
15 | 21603654 | The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response. | 2011 | 1 |
16 | 21129256 | [Effects of xbp-1 gene silencing on bortezomib-induced apoptosis in human multiple myeloma cells]. | 2010 Oct | 4 |
17 | 19391038 | Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells. | 2009 Jun | 1 |
18 | 18723477 | Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells. | 2008 Aug | 2 |